Specialty Pharmacy

Drug development and innovation could render the current specialty pharmacy model obsolete in 20 years.

Investigational drug demonstrates a substantial and clinically meaningful reduction in bleeds related to hemophilia.

The National HIV Testing Day annual campaign takes place on June 27th.

Data suggests favorable tolerability of novel treatment in patients with relapsed or refractory AML.

Rational design approaches could transform how multiple sclerosis is treated.

Top news of the day from across the health care landscape.

Adding an investigational diabetes drug to anti-cancer regimen may reduce cardiotoxicity.

CT-P10 is indicated to treat a form of non-Hodgkin lymphoma and rheumatoid arthritis.

A Complete Response Letter cited issues related to violations within a McPherson, KS, facility.

Differences in major risk factors and inequalities in health care access have resulted in substantial disparities in liver cancer mortality.

The guideline reinforces stereotactic body radiation therapy as the standard of care for medically inoperable patients with non-small cell lung cancer.

Scientists solve protein structures to reveal new treatment developments for diseases such as Ebola virus, Lyme disease, and tuberculosis .

Getting too much or too little sleep can elevate the risk of cancer.

Top news of the day from across the health care landscape.

Targeting KRAS mutations may lead to effective new pancreatic cancer treatments.

New analysis examines opioid use among patients with rheumatoid arthritis.

Alemtuzumab treats relapsing forms of multiple sclerosis, but is accompanied with a 50% risk of secondary autoimmune diseases.

Elvin Montanez, PharmD, chief operations officer at BioPlus Specialty Pharmacy, discusses optimal strategies when choosing a specialty pharmacy to partner with.

A look at last week's top stories in the world of pharmacy.

Top articles of the week on Specialty Pharmacy Times.

A next generation sequencing test to detect lung cancer mutation was also approved.

Non-small cell lung cancer vaccine harnesses peptides to increase immune response.

Top news of the day from across the health care landscape.

Subcutaneous administration of Rituxan Hycela shortens treatment length to only 5 to 7 minutes.

Forward-thinking pharmacies can capitalize on the rise of value-based care.

Patients with HIV-associated sensory neuropathy have a decrease in corneal nerve fiber density and an increase in corneal nerve tortuosity.

Could household pets be the key to treating breast carcinoma?

Restoring a tumor suppressing gene offers a promising therapeutic target for diffuse intrinsic pontine glioma.